CiNTL Pharma B.V. Announces the Expansion of Their Project Management Office (PMO) Led by Data Science Engineering Team

July 14, 2024

 

​

CiNTL Pharma B.V. Announces the Expansion of their PMO Led by Data Science Engineering Team

​

Leiden, The Netherlands, July 14, 2024 – CiNTL Pharma B.V. is pleased to announce the expansion of its Project Management Office (PMO), now spearheaded by a highly specialized Data Science Engineering team. This strategic move reinforces CiNTL Pharma’s commitment to driving innovation in clinical research through data-driven methodologies and advanced analytics.

​

“At CiNTL Pharma, we recognize the transformative power of data science in optimizing project management and clinical research operations,” said Yolanda Cabrera-Sybesma, Chief Executive Officer of CiNTL Pharma B.V. “By expanding our PMO with a dedicated Data Science Engineering team, we are equipping our organization with cutting-edge capabilities that will enhance efficiency, accelerate timelines, and drive smarter decision-making in drug development.”

​

The newly expanded PMO will focus on leveraging AI-powered analytics, predictive modeling, and automation to streamline clinical trial processes. By integrating advanced data science methodologies, CiNTL Pharma aims to improve trial efficiency, optimize resource allocation, and enhance risk management strategies across all research projects.

​

“Our Data Science Engineering team is uniquely positioned to redefine project management in the pharmaceutical industry,” added Cabrera-Sybesma. “This expansion marks a critical step in our journey to harness big data and AI-driven insights to ensure seamless execution of clinical trials and regulatory processes.”

​

With a commitment to technological excellence and industry-leading project management, CiNTL Pharma continues to set new benchmarks in clinical research innovation. The expanded PMO will play a vital role in scaling CiNTL Pharma’s operational capabilities and reinforcing its position as a trailblazer in the CRO landscape.​

​

For more information about CiNTL Pharma B.V. and its commitment to AI-driven clinical research innovation, visit www.cintlpharma.com.

​

CiNTL Pharma B.V. is a Contract Research Organization (CRO) that provides clinical research development, consultancy and data driven solution services to the pharmaceutical, biotechnology and life sciences industries.

​​​

For media inquiries, partnerships, or collaborations, please contact CiNTL Pharma Business Development at BD@cintlpharma.com.

​

Witness the future of intelligent clinical research – Experience CiNTL Pharma today.